Oxford Biomedica Solutions
0 followers
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceu... Read more
Org chart
Tim Kelly
Collapse
Patricia Daggett
Director Brand And Marketing
Amy P.
Director Regulatory And Product Quality
Lori Karpes
Director Drug Product Sciences
David Hamilton
Director Warehouse Operations
Diane Golebiowski
Director AAV Platform Development
Marissa Stanvick
Director
Stephen Boyd
Director Of Engineering
Volker Glidden
Director Of Information Technology
Kelly Quesada
Senior Vice President
Melissa P.
Director Of Finance Accounting And Financial Reporting
Ryan Dickerson
Associate Director CMC Portfolio Lead
